K. Yamanaka

发表

Impact of sorafenib on health‐related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation

H. Miyake, M. Fujisawa, T. Kurahashi, 2010, BJU international.

Enhanced expression of heat shock protein 27 following neoadjuvant hormonal therapy is associated with poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.

H. Miyake, M. Fujisawa, T. Kurahashi, 2006, Anticancer research.

Clinical Evaluation of Random Biopsy of Urinary Bladder in Patients with Superficial Bladder Cancer

A. Gotoh, H. Okada, S. Kamidono, 1998, International journal of urology : official journal of the Japanese Urological Association.

Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones

K. Harada, H. Miyake, T. Kurahashi, 2006, International journal of urology : official journal of the Japanese Urological Association.

Oncological Outcome Following Radical Prostatectomy in Patients with pT3 Prostate Cancer

H. Miyake, M. Fujisawa, I. Sakai, 2008, Current Urology.

Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl‐2 and Bcl‐xL genes

M. Gleave, L. Fazli, H. Miyake, 2006, BJU international.

Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy.

M. Gleave, H. Miyake, M. Fujisawa, 2008, Urology.

Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.

M. Gleave, H. Miyake, I. Hara, 2005, Molecular cancer therapeutics.

Expression of fibroblast growth factors in human non-papillary renal cell carcinoma: Correlation with tumor progression

H. Miyake, S. Kamidono, S. Arakawa, 1999, International Journal of Clinical Oncology.

Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.

H. Miyake, S. Kamidono, S. Arakawa, 1999, The Journal of urology.

Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administration

M. Micallef, M. Kurimoto, H. Miyake, 1999, Cancer Gene Therapy.

Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model

M. Micallef, M. Kurimoto, H. Miyake, 1999, Cancer Immunology, Immunotherapy.

Significance of human testicular mast cells and their subtypes in male infertility.

M. Fujisawa, H. Okada, S. Kamidono, 2000, Human reproduction.

Expression of MAGE genes in testicular germ cell tumors.

H. Miyake, H. Nagai, S. Kamidono, 1999, Urology.

Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience

H. Miyake, M. Fujisawa, J. Furukawa, 2006, Anti-cancer drugs.

Expression of MAGE genes in renal cell carcinoma.

H. Miyake, S. Kamidono, S. Arakawa, 1998, International journal of molecular medicine.

Clinicopathological Features of Patients with Biochemical Recurrence after Radical Prostatectomy without Progressive Rise in Serum Prostate-Specific Antigen

H. Miyake, M. Fujisawa, T. Kurahashi, 2006, Urologia Internationalis.

Usefulness of the Nadir Value of Serum Prostate-Specific Antigen Measured by an Ultrasensitive Assay as a Predictor of Biochemical Recurrence after Radical Prostatectomy for Clinically Localized Prostate Cancer

K. Harada, H. Miyake, T. Kurahashi, 2006, Urologia Internationalis.

Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes

M. Fujisawa, H. Okada, S. Kamidono, 2001, BJU international.

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation.

H. Miyake, M. Fujisawa, T. Kurahashi, 2010, Urologic oncology.

Elevation of serum levels of urokinase‐type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

H. Miyake, S. Kamidono, S. Arakawa, 1999, The Prostate.

Clinicopathological Features of Recurrence after Radical Cystectomy for Patients with Transitional Cell Carcinoma of the Bladder

K. Harada, H. Miyake, T. Kurahashi, 2005, International Urology and Nephrology.

A novel antireflux uretero‐ileal anastomosis for urinary diversion: an experimental study

M. Fujisawa, S. Kamidono, S. Arakawa, 2000, BJU international.

[Treatment of newly diagnosed stage D2 prostatic carcinoma with hormonal therapy alone, or chemotherapy agents in combination with hormones].

A. Fujii, K. Yamanaka, H. Tanaka, 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Interaction between CD44 and hyaluronic acid regulates human prostate cancer development.

H. Miyake, S. Kamidono, I. Okamoto, 1998, The Journal of urology.

Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells

H. Miyake, S. Kamidono, S. Arakawa, 1999 .

Calcium ionophore, ionomycin inhibits growth of human bladder cancer cells both in vitro and in vivo with alteration of Bcl-2 and Bax expression levels.

H. Miyake, S. Kamidono, S. Arakawa, 1999, The Journal of urology.

Reconstruction of Urinary Tract Combined with Surgical Management of Locally Advanced Non-Urological Cancer Involving the Genitourinary Organs

K. Harada, H. Miyake, T. Kurahashi, 2006, Urologia Internationalis.

Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.

H. Miyake, S. Kamidono, S. Arakawa, 1998, Anticancer research.

Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.

H. Miyake, S. Kamidono, S. Arakawa, 1998, The American journal of pathology.

Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence

H. Miyake, S. Kamidono, S. Arakawa, 1999, Cancer.

A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells

M. Gleave, L. Fazli, H. Miyake, 2005, Molecular Cancer Therapeutics.

Regression with secretory changes of ovary-independent rat mammary carcinoma by pharmacological doses of estrogen.

K. Matsumoto, Y. Kitamura, M. Yamada, 1985, Japanese journal of cancer research : Gann.

Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer

M. Gleave, L. Fazli, A. Hurtado-coll, 2004, Cancer Research.

Significance of radical cystectomy for bladder cancer in patients over 80 years old

H. Miyake, M. Fujisawa, I. Hara, 2006, International Urology and Nephrology.

Elevation of serum level of vascular endothelial growth factor as a new predictor of recurrence and disease progression in patients with superficial urothelial cancer.

H. Miyake, S. Kamidono, S. Arakawa, 1999, Urology.

Secreted type of modified interleukin-18 gene transduced into mouse renal cell carcinoma cells induces systemic tumor immunity.

H. Miyake, H. Nagai, S. Kamidono, 2001, The Journal of urology.

Papillary renal cell carcinoma: A clinicopathological study of 35 cases

H. Miyake, M. Fujisawa, K. Hanioka, 2006, International journal of urology : official journal of the Japanese Urological Association.

Elevation of urokinase-type plasminogen activator and its receptor densities as new predictors of disease progression and prognosis in men with prostate cancer.

H. Miyake, S. Kamidono, S. Arakawa, 1999, International journal of oncology.

Nephrostomy tract tumor seeding following percutaneous manipulation of a renal pelvic carcinoma.

Yuji Yamada, K. Yamanaka, K. Umezu, 2002, Hinyokika kiyo. Acta urologica Japonica.

[Pathological prognostic factors of renal pelvic and ureteral cancer].

M. Fujisawa, Kazushi Tanaka, I. Hara, 2006, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Oncological Outcome of Contemporary Radical Nephrectomy for pT1 Renal Cell Carcinoma: Comparison of Open versus Laparoscopic Approach

H. Miyake, M. Fujisawa, I. Sakai, 2011, Current Urology.

A giant renal cyst in a young man with increased carbohydrate antigen 19-9 in serum and cystic fluid.

M. Fujisawa, S. Kamidono, K. Yamanaka, 2001, The Journal of urology.

Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression.

H. Miyake, S. Kamidono, I. Hara, 2002, Oncology reports.

Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.

M. Gleave, H. Miyake, I. Hara, 2005, Oncology reports.

(HSP27) in prostate cancer before and after androgen withdrawal therapy and to assess the prognostic significance of HSP27 expression in patients undergoing radical prostatectomy

H. Miyake, M. Fujisawa, T. Kurahashi, 2008 .

Prognostic significance of insulin‐like growth factor (IGF) binding protein‐2 to IGF‐binding protein‐3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder

H. Miyake, I. Hara, M. Muramaki, 2005, BJU international.

Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.

M. Gleave, H. Miyake, I. Hara, 2005, Neoplasia.

Long-Term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for locally invasive transitional cell carcinoma of the urothelium

H. Miyake, S. Kamidono, S. Arakawa, 1999, International Journal of Clinical Oncology.

High dose chemotherapy including paclitaxel (T‐ICE) combined with peripheral blood stem cell transplantation for male germ cell tumor. Preliminary report

M. Fujisawa, J. Furukawa, I. Hara, 2005, International journal of urology : official journal of the Japanese Urological Association.

Urinary cytology and competitive reverse transcriptase-polymerase chain reaction analysis of a specific CD44 variant to detect and monitor bladder cancer.

H. Miyake, S. Kamidono, S. Arakawa, 1998, The Journal of urology.

Limited significance of routine excretory urography in the follow‐up of patients with superficial bladder cancer after transurethral resection

H. Miyake, M. Fujisawa, I. Hara, 2006, BJU international.

Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys.

H. Miyake, S. Kamidono, S. Arakawa, 1999, Urology.

Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8–10/CD44v10 competitive RT‐PCR

H. Miyake, S. Kamidono, I. Okamoto, 1998, International journal of cancer.

The significance of prostate-specific antigen alpha-1-antichymotrypsin complex and its indices for the detection of prostate cancer.

Yuji Yamada, K. Yamanaka, Y. Takechi, 2003, Hinyokika kiyo. Acta urologica Japonica.

Urinary levels of vascular endothelial growth factor in patients with prostate cancer as a predictor of disease progression.

H. Miyake, T. Kurahashi, I. Hara, 2005, Anticancer research.

Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.

H. Miyake, S. Kamidono, M. Nakajima, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension

H. Miyake, T. Kurahashi, I. Hara, 2005, BJU international.

Long-term follow-up in patients with bilateral testicular germ cell tumors: a report of ten cases

H. Miyake, S. Kamidono, S. Arakawa, 1999, International Journal of Clinical Oncology.

Enhanced expression of the secreted form of clusterin following neoadjuvant hormonal therapy as a prognostic predictor in patients undergoing radical prostatectomy for prostate cancer.

M. Gleave, H. Miyake, T. Kurahashi, 2005, Oncology reports.

Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model.

M. Gleave, H. Miyake, I. Hara, 2005, Oncology reports.

1088: Novel Bispecific Antisense Oligonucleotides Inhibiting both BCL-2 and BCL-XL Expression Induce Apoptosis and Enhance Chemosensitivity in Human Androgen-Independent Prostate Cancer Cells

M. Gleave, H. Miyake, U. Zangemeister‐Wittke, 2004 .

Clinical Study of Renal Cell Carcinoma with Brain Metastasis

A. Gotoh, H. Okada, S. Kamidono, 1998, International journal of urology : official journal of the Japanese Urological Association.

A case of Sweet's syndrome following septic pulmonary emboli after high‐dose chemotherapy for advanced testicular cancer

M. Fujisawa, Kazushi Tanaka, T. Miura, 2006, International journal of urology : official journal of the Japanese Urological Association.